Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLTFF - The US SHORT report, better, BUT why any at all??

<< Previous

Bullboard Posts

Next >>

Comment by xodcodeon Jan 29, 2022 3:59pm

271 Views

Post# 34375069

RE:RE:TLTFF - The US SHORT report, better, BUT why any at all??

Agreed: shorts are at risk of a fairly quick TLT price increase in the short term given the likelihood of imminent positive test results.

Technically, needs to break $0.38, next resistance at $0.48 and last resistance at $0.58.

Once through $0.58, no telling how far TLT runs!

<< Previous

Bullboard Posts

Next >>

Day trading vs. swing trading strategies for small-cap stocks